Antisense Oligonucleotide (ASO) Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: AA5462105A08EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antisense Oligonucleotide (ASO) Therapeutics in Global, including the following market information:

Global Antisense Oligonucleotide (ASO) Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antisense Oligonucleotide (ASO) Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pulmonary Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antisense Oligonucleotide (ASO) Therapeutics include Ionis Pharmaceuticals, Inc, Sarpeta Therapeutics Inc., Biogen Inc, Alnylam Pharmaceuticals, Inc, Antisense Therapeutics Limited, Arrowhead Pharmaceuticals Inc., Enzon Pharmaceuticals, Inc., Bio-Path Holdings, Inc. and GlaxoSmithKline PLC and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antisense Oligonucleotide (ASO) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antisense Oligonucleotide (ASO) Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antisense Oligonucleotide (ASO) Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Pulmonary Delivery
• Intravenous Injections
• Intradermal Injections
• Intraperitoneal Injections
• Topical Delivery
• Others

Global Antisense Oligonucleotide (ASO) Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antisense Oligonucleotide (ASO) Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Genetic Disorders
• Neurological Disorders
• Oncological Disorders
• Metabolic Disorders
• Ophthalmic Disorders
• Others

Global Antisense Oligonucleotide (ASO) Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antisense Oligonucleotide (ASO) Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antisense Oligonucleotide (ASO) Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antisense Oligonucleotide (ASO) Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Ionis Pharmaceuticals, Inc
• Sarpeta Therapeutics Inc.
• Biogen Inc
• Alnylam Pharmaceuticals, Inc
• Antisense Therapeutics Limited
• Arrowhead Pharmaceuticals Inc.
• Enzon Pharmaceuticals, Inc.
• Bio-Path Holdings, Inc.
• GlaxoSmithKline PLC
• Geron Corporation (Geron)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antisense Oligonucleotide (ASO) Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antisense Oligonucleotide (ASO) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTISENSE OLIGONUCLEOTIDE (ASO) THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size: 2021 VS 2028
2.2 Global Antisense Oligonucleotide (ASO) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antisense Oligonucleotide (ASO) Therapeutics Players in Global Market
3.2 Top Global Antisense Oligonucleotide (ASO) Therapeutics Companies Ranked by Revenue
3.3 Global Antisense Oligonucleotide (ASO) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antisense Oligonucleotide (ASO) Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antisense Oligonucleotide (ASO) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense Oligonucleotide (ASO) Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Antisense Oligonucleotide (ASO) Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antisense Oligonucleotide (ASO) Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antisense Oligonucleotide (ASO) Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Pulmonary Delivery
  4.1.3 Intravenous Injections
  4.1.4 Intradermal Injections
  4.1.5 Intraperitoneal Injections
  4.1.6 Topical Delivery
  4.1.7 Others
4.2 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2021 & 2028
  5.1.2 Genetic Disorders
  5.1.3 Neurological Disorders
  5.1.4 Oncological Disorders
  5.1.5 Metabolic Disorders
  5.1.6 Ophthalmic Disorders
  5.1.7 Others
5.2 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2028
  6.3.2 US Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.3.3 Canada Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2028
  6.4.2 Germany Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.4.3 France Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.4.5 Italy Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.4.6 Russia Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2028
  6.5.2 China Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.5.3 Japan Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.5.6 India Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.7.3 Israel Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028
  6.7.5 UAE Antisense Oligonucleotide (ASO) Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Ionis Pharmaceuticals, Inc
  7.1.1 Ionis Pharmaceuticals, Inc Corporate Summary
  7.1.2 Ionis Pharmaceuticals, Inc Business Overview
  7.1.3 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.1.4 Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Ionis Pharmaceuticals, Inc Key News
7.2 Sarpeta Therapeutics Inc.
  7.2.1 Sarpeta Therapeutics Inc. Corporate Summary
  7.2.2 Sarpeta Therapeutics Inc. Business Overview
  7.2.3 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.2.4 Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Sarpeta Therapeutics Inc. Key News
7.3 Biogen Inc
  7.3.1 Biogen Inc Corporate Summary
  7.3.2 Biogen Inc Business Overview
  7.3.3 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.3.4 Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Biogen Inc Key News
7.4 Alnylam Pharmaceuticals, Inc
  7.4.1 Alnylam Pharmaceuticals, Inc Corporate Summary
  7.4.2 Alnylam Pharmaceuticals, Inc Business Overview
  7.4.3 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.4.4 Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Alnylam Pharmaceuticals, Inc Key News
7.5 Antisense Therapeutics Limited
  7.5.1 Antisense Therapeutics Limited Corporate Summary
  7.5.2 Antisense Therapeutics Limited Business Overview
  7.5.3 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.5.4 Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Antisense Therapeutics Limited Key News
7.6 Arrowhead Pharmaceuticals Inc.
  7.6.1 Arrowhead Pharmaceuticals Inc. Corporate Summary
  7.6.2 Arrowhead Pharmaceuticals Inc. Business Overview
  7.6.3 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.6.4 Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Arrowhead Pharmaceuticals Inc. Key News
7.7 Enzon Pharmaceuticals, Inc.
  7.7.1 Enzon Pharmaceuticals, Inc. Corporate Summary
  7.7.2 Enzon Pharmaceuticals, Inc. Business Overview
  7.7.3 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.7.4 Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Enzon Pharmaceuticals, Inc. Key News
7.8 Bio-Path Holdings, Inc.
  7.8.1 Bio-Path Holdings, Inc. Corporate Summary
  7.8.2 Bio-Path Holdings, Inc. Business Overview
  7.8.3 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.8.4 Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Bio-Path Holdings, Inc. Key News
7.9 GlaxoSmithKline PLC
  7.9.1 GlaxoSmithKline PLC Corporate Summary
  7.9.2 GlaxoSmithKline PLC Business Overview
  7.9.3 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.9.4 GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline PLC Key News
7.10 Geron Corporation (Geron)
  7.10.1 Geron Corporation (Geron) Corporate Summary
  7.10.2 Geron Corporation (Geron) Business Overview
  7.10.3 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Major Product Offerings
  7.10.4 Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Geron Corporation (Geron) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antisense Oligonucleotide (ASO) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Antisense Oligonucleotide (ASO) Therapeutics Market Drivers in Global Market
Table 3. Antisense Oligonucleotide (ASO) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Antisense Oligonucleotide (ASO) Therapeutics in Global Market
Table 5. Top Antisense Oligonucleotide (ASO) Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antisense Oligonucleotide (ASO) Therapeutics Product Type
Table 9. List of Global Tier 1 Antisense Oligonucleotide (ASO) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antisense Oligonucleotide (ASO) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antisense Oligonucleotide (ASO) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Ionis Pharmaceuticals, Inc Corporate Summary
Table 31. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 32. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Sarpeta Therapeutics Inc. Corporate Summary
Table 34. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 35. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Biogen Inc Corporate Summary
Table 37. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 38. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Alnylam Pharmaceuticals, Inc Corporate Summary
Table 40. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 41. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Antisense Therapeutics Limited Corporate Summary
Table 43. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 44. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Arrowhead Pharmaceuticals Inc. Corporate Summary
Table 46. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 47. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Enzon Pharmaceuticals, Inc. Corporate Summary
Table 49. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 50. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Bio-Path Holdings, Inc. Corporate Summary
Table 52. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 53. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline PLC Corporate Summary
Table 55. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 56. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Geron Corporation (Geron) Corporate Summary
Table 58. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Product Offerings
Table 59. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Antisense Oligonucleotide (ASO) Therapeutics Segment by Type in 2021
Figure 2. Antisense Oligonucleotide (ASO) Therapeutics Segment by Application in 2021
Figure 3. Global Antisense Oligonucleotide (ASO) Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antisense Oligonucleotide (ASO) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antisense Oligonucleotide (ASO) Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antisense Oligonucleotide (ASO) Therapeutics Revenue in 2021
Figure 8. By Type - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antisense Oligonucleotide (ASO) Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antisense Oligonucleotide (ASO) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Ionis Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sarpeta Therapeutics Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biogen Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alnylam Pharmaceuticals, Inc Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Antisense Therapeutics Limited Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Arrowhead Pharmaceuticals Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Enzon Pharmaceuticals, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bio-Path Holdings, Inc. Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline PLC Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Geron Corporation (Geron) Antisense Oligonucleotide (ASO) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)